Flex Pharma Presenting at Upcoming Investor Conferences in September 2016

BOSTON--(BUSINESS WIRE)-- Click to Tweet

Flex Pharma, Inc. (NASDAQ: FLKS) today announced that it will present a corporate overview at the following upcoming investor conferences in September:

• The BioCentury NewsMakers Conference on September 9, 2016 at 11:30 a.m. in New York, NY;
• The Rodman & Renshaw 18th Annual Global Investment Conference on September 13, 2016 at 9:35 a.m. in New York, NY;
• The Mizuho Neuro-Focus Therapeutics Conference on September 21, 2016 in Boston, MA.

A live webcast of Flex Pharma’s presentations at these conferences may be accessed in the Investor section of the Company’s website at www.flex-pharma.com. Please log on to the Flex Pharma website approximately 15 minutes prior to the scheduled webcast to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Flex Pharma’s website for 2 weeks following each presentation.

About Flex Pharma

Flex Pharma, Inc. is a biotechnology company that is developing innovative and proprietary treatments for nocturnal leg cramps, cramps and spasms associated with severe neuromuscular conditions such as MS and ALS, and exercise-associated muscle cramps. Flex Pharma was founded by National Academy of Science members Rod MacKinnon, M.D. (2003 Nobel Laureate), and Bruce Bean, Ph.D., recognized leaders in the fields of ion channels and neurobiology, along with Chair and CEO Christoph Westphal, M.D., Ph.D.

Visit www.TeamHOTSHOT.com for updates and to learn more about HOTSHOTTM, the Company’s consumer product which is scientifically proven to prevent and treat muscle cramps.

HOTSHOTTM is a consumer product that is marketed to endurance athletes for exercise-associated muscle cramps. HOTSHOTTM complements the Company’s drug development business and is not intended to diagnose, treat, cure or prevent any disease.

Follow Flex Pharma (@flexpharma) and HOTSHOTTM (@Team_HOTSHOT) on Twitter

View source version on businesswire.com: http://www.businesswire.com/news/home/20160901005695/en/

Flex Pharma, Inc.
Elizabeth Woo, 617-874-1829
SVP, Investor Relations & Corporate Communications
[email protected]

Source: Flex Pharma

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• KBRA Publishes Ratings for Hildene Holding Company, LLC and Hildene Capital Management, LLC
• Researchers Test Simple Fix That Saves Time Spent in ERs 
• Stateside Associates Names Johnathan Lozier President as Mark Anderson Transitions to Chairman